(Q42181000)

English

Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study.

scientific article published on 21 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Charing Ching-Ning Chong

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

G L H Wong

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

V W S Wong

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

P C T Ip

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Y S Cheung

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J Wong

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

K F Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

P B S Lai

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

H L Y Chan

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

0 references

publication date

21 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

199-208

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Chronic hepatitis B: update 2009

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Asian-Pacific consensus statement on the management of chronic hepatitis B: an update

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: can we predict earlier?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Recurrent hepatocellular carcinoma: it's the virus!

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

A study into the risk of exacerbation of chronic hepatitis B after liver resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Immunosuppression following surgical and traumatic injury

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Antiviral therapy decreases viral reactivation in patients with hepatitis B virus-related hepatocellular carcinoma undergoing hepatectomy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13034

21 January 2018

Identifiers

10.1111/APT.13034

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25413146%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42181000&oldid=1566154773"